Australia’s regulator has issued warnings about the risk of suicidal thoughts and lower effectiveness of contraceptives in ...

Scientists are testing whether GLP-1 drugs can help to cut cravings for cigarettes, alcohol and opioids — as well as food.

A similarly designed study in patients with both obesity and diabetes, published in Retina, also linked GLP-1 drugs to lower ...

Weight loss drug Ozempic has caused quite a stir this year, with many linking it to drastic celebrity weight loss. While ...

HORRENDOUS hangovers are just one of the side effects that people taking fat jabs might experience during Christmas party ...

Peptides promoted by influencers on social media promise miraculous results of healing, regeneration, and growth. But is it ...

What are called autoimmune diseases can affect just about every part of the body — and tens of millions of people. While most ...

Marketers are positioning weight-loss shots as cosmetic elixirs for anyone who wants to lose a few pounds. Doctors warn that ...

And Big Pharma’s not done cashing in on the weight-loss boom. Drugmakers are readying a new wave of next-level GLP-1 treatments, with several promising candidates in the pipeline. These experimental ...

By integrating HIV care with non-communicable disease prevention and care, healthcare systems can help people living with HIV ...

Knowing that naloxone works by stalling the µ-opioid receptor in an early, latent state suggests that molecules that can bind more tightly or more selectively to this form of the receptor could be ...

New research finds that popular type 2 diabetes drug metformin can impact the brain. Here’s why that matters and what it means for treatment, per doctors.